SETDB2 and acute lymphoblastic leukemia: Lin et al. reported that the transcription factor E2A-PBX1 suppressed the expression of the cell cycle inhibitor CDKN2C by mediating the epigenetic regulator SETDB2’s expression, thus establishing an oncogenic pathway in ALL [57].